Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
AI
Tech
Science

Biogen
Biotech
Topics

Advertisement

Advertisement

Biogen

Share

Top Latest Popular

Yesterday

Biogen (BIIB) Alzheimer’s Updates Put Fair Value Questions Back In Focus Simply Wall St 15:40 Sat, 07 Nov

Watchdog probes U.S. drugmaker Biogen over restricted access to multiple sclerosis test NL Times 12:55 Sat, 07 Nov

Friday

Kenvue Now #267 Largest Company, Surpassing Biogen Nasdaq 22:05 Fri, 06 Nov

Advertisement

Advertisement

Thursday

Biogen Provides Update on Private Payer Coverage for Zurzuvae™ (zuranolone) Business Wire (Press Release) 16:03 Thu, 05 Nov

Alzheimer’s Data Update Could Be A Key Test For Biogen Stock (BIIB) Simply Wall St 12:43 Thu, 05 Nov

In the last month

Biogen to Present New Data Across Alzheimer's Disease Portfolio at CTAD 2026 Biogen (Press Release) 11:07 Thu, 29 Oct

Biogen Inc. (BIIB) Tops Q3 Earnings and Revenue Estimates Zacks 12:59 Wed, 28 Oct

Sales of Leqembi® totaled 32.2 billion yen in the third quarter 2026 PR Newswire (Press Release) 10:27 Wed, 28 Oct

Kos Biotechnology Partners Announces Strategic Investment in Golden Age Health to Accelerate Global Access to Rare Disease Therapies PR Newswire (Press Release) 22:04 Mon, 26 Oct

Biogen Q3 Preview: Will Growth Products Drive an Earnings Beat? Zacks 14:46 Mon, 26 Oct

Biogen (BIIB) Surges 5.3%: Is This an Indication of Further Gains? Zacks 13:29 Fri, 23 Oct

DHL Supply Chain and Biogen expand health logistics partnership in Türkiye The Stat Trade Times 15:49 Thu, 22 Oct

The Zacks Analyst Blog Highlights BridgeBio Pharma, Intellia Therapeutics, Biogen and Viking Therapeutics Zacks 15:16 Wed, 21 Oct

Biogen to Present New Data Across Nephrology Portfolio, Including Long-term EMPAVELI® (pegcetacoplan) Phase 3 Results, at American Society of Nephrology (ASN) Kidney Week Biogen (Press Release) 12:40 Mon, 19 Oct

Biogen-backed Estuary nabs $93M for kidney disease gene therapy BioPharma Dive 13:45 Fri, 16 Oct

Advertisement

Biogen Preliminary Third Quarter 2026 Acquired In-Process Research and Development Charges Biogen (Press Release) 22:34 Thu, 15 Oct

Teen begs Andy Burnham for life-extending drugs as mum helplessly forced to watch decline The Mirror 15:20 Thu, 15 Oct

Local life sciences scene ‘can’t just rest on our laurels,’ Biogen CEO warns Boston Globe 14:18 Tue, 13 Oct

Biogen announces phase 2 data for cutaneous lupus erythematosus PMLiVE 13:16 Thu, 08 Oct

Advertisement

Advertisement

About our Biogen News

Biogen is an American multinational biotechnology company that specialises in treatment of neurological diseases.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna